Hung Ming-Jui, Mao Chun-Tai, Hung Ming-Yow, Chen Tien-Hsing
From the Division of Cardiology, Department of Medicine, Chang Gung Memorial Hospital, Keelung, Chang Gung University College of Medicine, Keelung City, Taiwan (MJH, CTM, THC); Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan (MYH); Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan (MYH); and Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan (MYH).
Medicine (Baltimore). 2015 Oct;94(42):e1880. doi: 10.1097/MD.0000000000001880.
Although asthma increases the risk of cardiovascular disease, little is known about the relation of asthma and its severity to coronary vasospastic angina (CVsA). We hypothesized that asthma contributed to the development of CVsA.Patients in this population-based cohort study were retrospectively collected from the Taiwan National Health Insurance database. Using propensity score matching, subjects were stratified at a 1 : 4 ratio into a study group comprising 3087 patients with a diagnosis of CVsA, and a control group consisting of 12,348 patients who underwent coronary intervention for obstructive coronary artery disease (CAD) during the period 2000 to 2011.Asthma significantly increased the risk of new-onset CVsA independent of other comorbidities [adjusted odds ratio (OR) = 1.85, 95% confidence interval (95% CI) = 1.47-2.32, P < 0.001]. In addition, the risk of new-onset CVsA was significantly higher in previous users of oral or inhaled corticosteroids (oral corticosteroids: OR = 1.22, 95% CI = 1.01-1.49, P = 0.04; inhaled corticosteroids: OR = 1.89, 95% CI = 1.28-2.79, P = 0.001). In addition, the prevalence of asthma was highest among patients with CVsA alone, followed by patients with CAD and CVsA and patients who underwent coronary intervention for CAD alone (P trend < 0.001).Our study suggests that asthma is independently associated with CVsA and prior steroid use increases the risk of CVsA development.
尽管哮喘会增加心血管疾病的风险,但对于哮喘及其严重程度与冠状动脉痉挛性心绞痛(CVsA)之间的关系却知之甚少。我们推测哮喘会促使CVsA的发生。
在这项基于人群的队列研究中,患者数据是从台湾国民健康保险数据库中回顾性收集的。采用倾向评分匹配法,将受试者按1:4的比例分层,分为一个由3087例诊断为CVsA的患者组成的研究组,以及一个由12348例在2000年至2011年期间因阻塞性冠状动脉疾病(CAD)接受冠状动脉介入治疗的患者组成的对照组。
哮喘显著增加了新发CVsA的风险,且独立于其他合并症[调整后的优势比(OR)=1.85,95%置信区间(95%CI)=1.47 - 2.32,P<0.001]。此外,既往使用口服或吸入性糖皮质激素的患者发生新发CVsA的风险显著更高(口服糖皮质激素:OR = 1.22,95%CI = 1.01 - 1.49,P = 0.04;吸入性糖皮质激素:OR = 1.89,95%CI = 1.28 - 2.79,P = 0.001)。此外,仅患有CVsA的患者中哮喘患病率最高,其次是患有CAD和CVsA的患者以及仅因CAD接受冠状动脉介入治疗的患者(P趋势<0.001)。
我们的研究表明,哮喘与CVsA独立相关,既往使用类固醇会增加CVsA发生的风险。